Add to Favourites
To login click here
The article discusses the constantly evolving landscape of healthcare’s current data regulatory landscape, particularly in regards to the use of artificial intelligence (AI) and other intelligent agents such as machine learning and natural language processing. The author, Uwe Trinks, an expert in pharmacovigilance technology, highlights the need for clear regulations in this area and discusses recent guidance papers and regulations in the European Union and the United States.